Company intelligence / Profile preview

Cnpair Biotech

Hangzhou, Zhejiang, Chinacnpair.com ↗

Ownership: Private
Employees: ~53
Development stage: Commercial

Overview

Cnpair Biotech is an ISO 13485-certified provider of high-quality core raw materials—such as monoclonal/polyclonal antibodies and recombinant/native proteins—for the global in vitro diagnostics industry. Its products support assay development for infectious diseases, cancer/tumor biomarkers, cardiac conditions, inflammation/hormone testing and more. The company serves both domestic Chinese and international clients with R&D/manufacturing based in Hangzhou.

Therapeutic areas: OncologyCardiovascularImmunologyInfectious Diseases
Modalities: AntibodyRecombinant proteinNative antigenEnzyme
Industry: Chemicals & Materials

Partnerships

No specific major pharmaceutical or biotech partnerships disclosed publicly. The company collaborates broadly with IVD manufacturers globally.

Beyond the preview

Go deeper on Cnpair Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cnpair Biotech.

Explore the full profile